BioCentury
ARTICLE | Clinical News

PerSeptive regulatory update

September 19, 1994 7:00 AM UTC

The Cambridge, Mass., company received U.S. Patent No. 5,306,426 covering its trace contaminant enrichment assay, a method of detecting and identifying trace substances that threaten the purity of bio...